Despite continued underperformance in 2024, the biotech sector enters 2025 with a brighter outlook driven by groundbreaking ...

The next leap in AI-driven healthcare requires brain power, a huge investment of money, and the courage to implement.

The AlphaMeld platform empowers key functional stakeholders, including those involved in early drug discovery, target identification, competitive intelligence, and clinical trial optimization. By ...

Multi-Modal Models: A multi-modal discovery approach was implemented that engineered-in potency against the novel target and engineered-out a specific off-target interaction. The NCE library displayed ...

Genialis, the RNA biomarker company, today announced an extension of its collaboration with Debiopharm, a Swiss-based ...

LinkedIn (MSFT) co-founder and venture capitalist Reid Hoffman on Monday launched an AI startup aimed at discovering new ...

Quantum computing and artificial intelligence (AI) can be combined with classical computing methods to design and discover small-molecule candidates that target the cancer-driving KRAS protein, ...

AI can help farmers anticipate and respond to the effects of climate change, such as altered growing seasons, pest invasions, ...

With continued investment and growing buzz from the industry, the AI hype is expected to extend through 2025 and beyond.

Research co-led by University of Toronto researchers and Insilico Medicine has demonstrated the potential of quantum ...